Table of Contents
ISRN Obstetrics and Gynecology
Volume 2012, Article ID 245756, 11 pages
http://dx.doi.org/10.5402/2012/245756
Review Article

Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer

1Division of Gynecologic Oncology, “Angelo Nocivelli” Institute of Molecular Medicine, University of Brescia, 25123 Brescia, Italy
2Department of Clinical Pathology, Regional Center for Biomarkers, Azienda ULSS 12, 30122 Venice, Italy
3Department of Biomedical Sciences and Biotechnology, Medical Statistics Unit, University of Brescia, 25123 Brescia, Italy
4Istituto Oncologico Veneto IOV-IRCCS, 35128 Padova, Italy
5Department of Obstetrics and Gynecology and Reproductive Sciences, Yale University School of Medicine, New Haven, CT 06511, USA

Received 20 February 2012; Accepted 3 April 2012

Academic Editors: E. Ginsburg and Y. S. Song

Copyright © 2012 Elisabetta Bandiera et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Elisabetta Bandiera, Roberta Franceschini, Claudia Specchia, et al., “Prognostic Significance of Vascular Endothelial Growth Factor Serum Determination in Women with Ovarian Cancer,” ISRN Obstetrics and Gynecology, vol. 2012, Article ID 245756, 11 pages, 2012. https://doi.org/10.5402/2012/245756.